2 Years After Germany's Regulation For Digital Health Apps, What Can We Learn?
At the end of 2019, the Digital Healthcare Act (Digitales Versorgungsgesetz, DVG) introduced a dedicated pathway enabling reimbursement of digital health...
Lorenzo D’Angelo is a principal in the Life Sciences Practice of CRA. He has considerable experience consulting with global pharmaceutical and medical device companies on their commercial strategies.
Lorenzo has supported clients in taking strategic decisions as well as implementing them along the product lifecycle: assessing new opportunities, developing a launch strategy and supporting a launch operationally, understanding and segmenting markets and customers to find new opportunities to grow. In these projects he leverages his multiple years of experience in collaborative scientific/industrial research, project management, market research, and analytical and statistical methodologies. In recent work he supervised projects developing commercial and medical strategies, understanding market and customer segments as well as evaluating assets and forecasting their potential return. His work is focused on Europe and the US but includes other growing markets in Asia, Latin America and beyond.
Prior to joining CRA, Lorenzo was a research group leader at TU München. He has participated in scientific conferences around the world and has published book chapters and articles in academic journals. His background in medical device engineering drives him to find new solutions in life sciences that can go from lab development to market launch and beyond.